Breaking News Instant updates and real-time market news.

FINL

Finish Line

$11.01

-0.98 (-8.17%)

, FL

Foot Locker

$34.38

-13.32 (-27.92%)

07:24
08/21/17
08/21
07:24
08/21/17
07:24

Finish Line downgraded to Sell from Neutral at UBS

UBS analyst Michael Binetti downgraded Finish Line (FINL) to Sell from Neutral based on the structural risks exposed by Foot Locker (FL) in its Q2 report. The analyst sees an incremental risk of a more rapid deterioration in Finish Line's core mid/lower tier markets versus Foot Locker. He also sees lower gross margins, prompting Binetti to lower his price target to $9 from $14 on Finish Line shares.

FINL

Finish Line

$11.01

-0.98 (-8.17%)

FL

Foot Locker

$34.38

-13.32 (-27.92%)

FINL Finish Line
$11.01

-0.98 (-8.17%)

07/24/17
RAJA
07/24/17
NO CHANGE
RAJA
Market Perform
Hibbett warning has negative read-through for Under Armour, says Raymond James
Raymond James analyst Dan Wewer noted that Hibbett Sports' (HIBB) same-store sales warning follows Finish Line's (FINL) Q1 release on June 23 that May sales suffered from weak consumer traffic and difficult product launch comparisons. The read through is negative for Hibbett's vendors, including Under Armour (UAA), said Wewer, who added that it also appears negative for Dick's Sporting Goods (DKS), though he is not sure if Hibbett's sales trends were company specific or reflective of the industry.
08/01/17
FBCO
08/01/17
NO CHANGE
Target $52
FBCO
Neutral
Foot Locker price target lowered to $52 from $66 at Credit Suisse
Credit Suisse analyst Christian Buss lowered his price target for Foot Locker (FL) to $52 from $66 given increasing industry headwinds and following disappointing commentary by peers Finish Line (FINL) and Hibbett Sports (HIBB). The analyst believes the best-in-class execution by Foot Locker may no longer be enough. He reiterates a Neutral rating on Foot Locker's shares.
08/18/17
SBSH
08/18/17
NO CHANGE
Target $81
SBSH
Buy
Foot Locker results and guidance 'greatly disappoints,' says Citi
Citi analyst Kate McShane says Foot Locker's (FL) Q2 results and outlook "greatly disappoints." The company posted its first negative comp since Q4 of 2009, McShane tells investors in a post-earnings research note. Along with Foot Locker, the analyst expects weakness in shares of Nike (NKE) and Finish Line (FINL) as well as Under Armour (UAA, UA) and Dick's Sporting Goods (DKS). McShane currently has a Buy rating on Foot Locker.
08/18/17
BOFA
08/18/17
DOWNGRADE
BOFA
Underperform
Finish Line downgraded to Underperform from Neutral at BofA/Merrill
FL Foot Locker
$34.38

-13.32 (-27.92%)

08/18/17
BOFA
08/18/17
DOWNGRADE
BOFA
Underperform
Foot Locker downgraded to Underperform from Neutral at BofA/Merrill
08/18/17
ADAM
08/18/17
DOWNGRADE
ADAM
Hold
Foot Locker downgraded to Hold from Buy at Canaccord
08/21/17
BARD
08/21/17
DOWNGRADE
BARD
Neutral
Foot Locker downgraded to Neutral from Outperform at Baird
08/21/17
UBSW
08/21/17
DOWNGRADE
Target $37
UBSW
Neutral
Foot Locker downgraded to Neutral from Buy at UBS
UBS analyst Michael Binetti downgraded Foot Locker (FL) to Neutral from Buy following Q2 results. The results, which were worse than the analyst expected, make it tougher to support a thesis that athletic retail will be able to sidestep the structural challenges of the broader sector, said Binetti, who also sees additional challenges and potential market share loss from Amazon.com (AMZN). Binetti lowered his price target to $37 from $70 on Foot Locker shares.

TODAY'S FREE FLY STORIES

PLYA

Playa Hotels & Resorts

$11.31

0.03 (0.27%)

09:00
01/18/18
01/18
09:00
01/18/18
09:00
Syndicate
Playa Hotels & Resorts 6M share Block Trade priced at $10.80 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

RARX

RA Pharmaceuticals

09:00
01/18/18
01/18
09:00
01/18/18
09:00
Initiation
RA Pharmaceuticals initiated  »

RA Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
01/18/18
01/18
09:00
01/18/18
09:00
General news
The 41k initial claims drop to a 45-year low of 220k »

The 41k initial claims…

AGIO

Agios Pharmaceuticals

$70.33

1.53 (2.22%)

08:59
01/18/18
01/18
08:59
01/18/18
08:59
Recommendations
Agios Pharmaceuticals analyst commentary  »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 19

    Jan

PRTK

Paratek Pharmaceuticals

$17.68

-0.075 (-0.42%)

08:59
01/18/18
01/18
08:59
01/18/18
08:59
Syndicate
Paratek Pharmaceuticals 3.11M share Spot Secondary priced at $16.10 »

BTIG acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

ALXN

Alexion

$122.12

-2.36 (-1.90%)

08:59
01/18/18
01/18
08:59
01/18/18
08:59
Initiation
Alexion initiated  »

Alexion assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTZ

MasTec

$51.90

0.75 (1.47%)

08:59
01/18/18
01/18
08:59
01/18/18
08:59
Recommendations
MasTec analyst commentary  »

MasTec price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLR

Continental Resources

$57.18

0.25 (0.44%)

08:57
01/18/18
01/18
08:57
01/18/18
08:57
Downgrade
Continental Resources rating change  »

Continental Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GATX

GATX

$65.21

-0.5 (-0.76%)

08:57
01/18/18
01/18
08:57
01/18/18
08:57
Earnings
GATX reports Q4 non-GAAP EPS 68c, consensus 73c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

XLRN

Acceleron

$44.99

-0.03 (-0.07%)

08:57
01/18/18
01/18
08:57
01/18/18
08:57
Initiation
Acceleron initiated  »

Acceleron assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDX

Becton Dickinson

$231.37

2.83 (1.24%)

08:56
01/18/18
01/18
08:56
01/18/18
08:56
Hot Stocks
Becton Dickinson says enrollment complete in Lutonix below-the-knee trial »

BD announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 06

    Feb

SCHW

Charles Schwab

$56.09

0.56 (1.01%)

08:55
01/18/18
01/18
08:55
01/18/18
08:55
Recommendations
Charles Schwab analyst commentary  »

Charles Schwab price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$31.18

-0.06 (-0.19%)

, GE

General Electric

$17.35

-0.86 (-4.72%)

08:55
01/18/18
01/18
08:55
01/18/18
08:55
Options
Notable open interest changes for January 18th »

Wednesday's total…

BAC

Bank of America

$31.18

-0.06 (-0.19%)

GE

General Electric

$17.35

-0.86 (-4.72%)

FB

Facebook

$177.60

-0.79 (-0.44%)

BABA

Alibaba

$183.83

1.43 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 07

    Feb

  • 15

    Feb

  • 28

    Feb

08:55
01/18/18
01/18
08:55
01/18/18
08:55
General news
U.S. housing starts dropped 8.2% to 1.192 M in December »

U.S. housing starts…

ABM

ABM

$38.73

0.26 (0.68%)

08:55
01/18/18
01/18
08:55
01/18/18
08:55
Conference/Events
ABM to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AMGP

Antero Midstream GP

$20.89

-0.11 (-0.52%)

, AM

Antero Midstream Partners

$30.95

-0.8 (-2.52%)

08:55
01/18/18
01/18
08:55
01/18/18
08:55
Conference/Events
Antero Resources to host analyst day »

Analyst Day to be held in…

AMGP

Antero Midstream GP

$20.89

-0.11 (-0.52%)

AM

Antero Midstream Partners

$30.95

-0.8 (-2.52%)

AR

Antero Resources

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

BIVV

Bioverativ

$62.32

-1.55 (-2.43%)

08:54
01/18/18
01/18
08:54
01/18/18
08:54
Initiation
Bioverativ initiated  »

Bioverativ assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 25

    Apr

UTHR

United Therapeutics

$140.32

5.2 (3.85%)

08:54
01/18/18
01/18
08:54
01/18/18
08:54
Initiation
United Therapeutics initiated  »

United Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$82.47

2.05 (2.55%)

08:53
01/18/18
01/18
08:53
01/18/18
08:53
Recommendations
PayPal analyst commentary  »

PayPal Q4 may see upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

EDGE

Edge Therapeutics

08:52
01/18/18
01/18
08:52
01/18/18
08:52
Initiation
Edge Therapeutics initiated  »

Edge Therapeutics assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$90.14

1.79 (2.03%)

08:52
01/18/18
01/18
08:52
01/18/18
08:52
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 31

    Jan

  • 07

    Feb

SNAP

Snap

$13.52

0.02 (0.15%)

, FB

Facebook

$177.60

-0.79 (-0.44%)

08:52
01/18/18
01/18
08:52
01/18/18
08:52
Conference/Events
SunTrust Internet & digital media analyst holds analyst/industry conference call »

Internet & Digital…

SNAP

Snap

$13.52

0.02 (0.15%)

FB

Facebook

$177.60

-0.79 (-0.44%)

GOOG

Alphabet

$1,131.98

10.22 (0.91%)

GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

TWTR

Twitter

$24.56

-0.1 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

  • 18

    Mar

BMRN

BioMarin

$89.64

-0.6 (-0.66%)

08:52
01/18/18
01/18
08:52
01/18/18
08:52
Initiation
BioMarin initiated  »

BioMarin assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 25

    May

LEN

Lennar

$70.71

1.93 (2.81%)

08:51
01/18/18
01/18
08:51
01/18/18
08:51
Upgrade
Lennar rating change  »

Lennar upgraded to Buy at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICBK

County Bancorp

$30.73

-1.57 (-4.86%)

08:51
01/18/18
01/18
08:51
01/18/18
08:51
Earnings
County Bancorp reports Q4 EPS 30c, consensus 47c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.